Alice Alejandro F, Kramer Gwen, Bambina Shelly, Baird Jason R, Bahjat Keith S, Gough Michael J, Crittenden Marka R
Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213; and.
Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213; and
J Immunol. 2018 Jan 1;200(1):177-185. doi: 10.4049/jimmunol.1700909. Epub 2017 Nov 17.
Although prophylactic vaccines provide protective humoral immunity against infectious agents, vaccines that elicit potent CD8 T cell responses are valuable tools to shape and drive cellular immunity against cancer and intracellular infection. In particular, IFN-γ-polarized cytotoxic CD8 T cell immunity is considered optimal for protective immunity against intracellular Ags. Suppressor of cytokine signaling (SOCS)1 is a cross-functional negative regulator of TLR and cytokine receptor signaling via degradation of the receptor-signaling complex. We hypothesized that loss of SOCS1 in dendritic cells (DCs) would improve T cell responses by accentuating IFN-γ-directed immune responses. We tested this hypothesis using a recombinant vaccine platform that targets CD11c DCs in mice in which SOCS1 is selectively deleted in all CD11c cells. Unexpectedly, in mice lacking SOCS1 expression in CD11c cells, we observed a decrease in CD8 T cell response to the vaccine. NK cell responses were also decreased in mice lacking SOCS1 expression in CD11c cells but did not explain the defect in CD8 T cell immunity. We found that DCs lacking SOCS1 expression were functional in driving Ag-specific CD8 T cell expansion in vitro but that this process was defective following infection in vivo. Instead, monocyte-derived innate TNF-α and inducible NO synthase-producing DCs dominated the antibacterial response. Thus, loss of SOCS1 in CD11c cells skewed the balance of immune response to infection by increasing innate responses while decreasing Ag-specific adaptive responses to infectious Ags.
尽管预防性疫苗可提供针对感染因子的保护性体液免疫,但能引发强大CD8 T细胞反应的疫苗是塑造和驱动针对癌症及细胞内感染的细胞免疫的宝贵工具。特别是,IFN-γ极化的细胞毒性CD8 T细胞免疫被认为是针对细胞内抗原的保护性免疫的最佳方式。细胞因子信号转导抑制因子(SOCS)1是TLR和细胞因子受体信号转导的跨功能负调节因子,它通过降解受体信号复合物发挥作用。我们假设,树突状细胞(DC)中SOCS1的缺失会通过增强IFN-γ导向的免疫反应来改善T细胞反应。我们使用一种重组疫苗平台对这一假设进行了测试,该平台靶向小鼠中的CD11c DC,其中SOCS1在所有CD11c细胞中被选择性删除。出乎意料的是,在CD11c细胞中缺乏SOCS1表达的小鼠中,我们观察到CD8 T细胞对疫苗的反应降低。在CD11c细胞中缺乏SOCS1表达的小鼠中,NK细胞反应也降低了,但这并不能解释CD8 T细胞免疫的缺陷。我们发现,缺乏SOCS1表达的DC在体外驱动抗原特异性CD8 T细胞扩增方面具有功能,但在体内感染后这一过程存在缺陷。相反,单核细胞衍生的先天性TNF-α和诱导型一氧化氮合酶产生型DC主导了抗菌反应。因此,CD11c细胞中SOCS1的缺失通过增加先天性反应同时减少对感染性抗原的抗原特异性适应性反应,使免疫反应对感染的平衡发生了倾斜。